semaglutide heart failure trial in Patients with with Preserved Ejection Fraction and Obesity The SELECT Trial - A
Description
This pattern is normal and expectedmost patients report that nausea becomes minimal or absent by their second or third month once they reach their effective therapeutic dose
These medicines work by mimicking the action of naturally occurring GLP-1, an incretin hormone released by the intestines in response to food intake
doi:10.1186/1475-2840-13-80
A common and reasonable question is whether you have to stop the GLP-1 medication if a gallbladder problem develops
